School of Medicine
Showing 1-31 of 31 Results
-
Alma-Martina Cepika
Instructor, Pediatrics - Stem Cell Transplantation
Research Asst., Pediatrics - Hematology/OncologyCurrent Role at StanfordAs an Instructor at Stanford, working in the laboratory of cell and gene therapy pioneer Dr. Maria Grazia Roncarolo, Dr. Cepika co-led an acute myeloid leukemia (AML) project. She designed an RNA-sequencing-based "interactomics" assay, identifying CD200 overexpression and ICAM1 deficiency as mechanisms of AML resistance to T-cell killing, correlating with poor patient survival. Currently, she investigates regulatory T cell (Treg) biology and Treg subsets in health and disease. She has identified the mechanisms of suppression and long-term in vivo persistence of alloantigen-specific type 1 regulatory T (Tr1) cells, and is the lead scientist of the ongoing phase I/Ib clinical trial (ClinicalTrials.gov ID NCT04640987), testing these Tr1 cells as a therapy in leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Finally, her recent single-cell transcriptomic and epigenomic analyses identified key transcriptional regulators of human Tr1 cells and Tr1-like cells in human tumors.
-
Pablo Domizi, Ph.D.
Senior Research Scientist-Basic Life, Pediatrics - Hematology/Oncology
BioI am passionate about translational research and how single cell technologies could open up new avenues for better and more accurate predictive models. Currently, I am focus on integrating single cell RNA and protein expression data to develop models to predict patient at risk for Antigen Loss relapse after CAR T cells immunotherapy.
-
Y. Lucy Liu, MD, PhD
Senior Research Scientist, Pediatrics - Hematology/Oncology
Current Role at StanfordSenior Research Scientist
